Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search


Decisions of Interest
October 07, 2003
Recent rulings of importance to your practice.
Employers Can Deny Coverage for Certain Infertility Treatments
October 07, 2003
An employer's medical plan that denies coverage for certain female-only infertility procedures does not violate either the Pregnancy Disability Act (PDA) or Title VII of the Civil Rights Act of 1964. The Second Circuit, in a ruling of first impression, concluded that neither are violated.
Property Condition Disclosure Act: The First Published Court Test
October 07, 2003
The Property Condition Disclosure Act (PCDA), which became effective on March 1, 2002, requires a seller of residential real property to deliver to a buyer a Property Condition Disclosure Statement (PCDS) before the buyer signs a binding contract. In <i>Malach v. Chuang, infra</i>, a Richmond County Civil Court judge construed ' for the first time ' the remedy provisions of the statute (R.P.L. sec. 465).
Real Property Law
October 07, 2003
Analysis of the latest cases of interest to your practice.
Landlord & Tenant
October 07, 2003
A rundown of the latest cases.
ONLINE: How to Research Human Organ Damage
If your product liability case involves damage to a specific organ, <i>eg,</i> heart damage allegedly caused by the use of fen-phen, professional organizations such as the American College of Cardiology (ACC) may offer some assistance. You can go to the association's Web site (www.acc.org) for information on a number of conditions.
CASE NOTES
Highlights of the latest intellectual property cases from around the country.
Daubert: 10 Years Later
<i>This is the first of a two-part article. Part two will appear next month.</i> Product liability practitioners must be intimately familiar with the strategy and tactics of challenging expert testimony under Rule 702, Fed. R. Evid., and the so-called <i>Daubert</i> trilogy of cases. Nearly 10 years ago, the United States Supreme Court, in <i>Daubert v. Merrill Dow Pharmaceuticals, Inc.</i>, 509 U.S. 579 (1993), vastly changed the road map for the admission of expert testimony. A body of case law has grown since that decision, providing numerous avenues to challenge admission of expert testimony. Because product liability cases usually rely on expert testimony, <i>Daubert</i> challenges are particularly important in them.
Development
October 07, 2003
The latest rulings you need to know.
Cooperatives & Condominiums
October 07, 2003
The latest rulings of importance to you and your practice.

MOST POPULAR STORIES

  • Private Equity Valuation: A Significant Decision
    Insiders (and others) in the private equity business are accustomed to seeing a good deal of discussion ' academic and trade ' on the question of the appropriate methods of valuing private equity positions and securities which are otherwise illiquid. An interesting recent decision in the Southern District has been brought to our attention. The case is <i>In Re Allied Capital Corp.</i>, CCH Fed. SEC L. Rep. 92411 (US DC, S.D.N.Y., Apr. 25, 2003). Judge Lynch's decision is well written, the Judge reviewing a motion to dismiss by a business development company, Allied Capital, against a strike suit claiming that Allied's method of valuing its portfolio failed adequately to account for i) conditions at the companies themselves and ii) market conditions. The complaint appears to be, as is often the case, slap dash, content to point out that Allied revalued some of its positions, marking them down for a variety of reasons, and the stock price went down - all this, in the view of plaintiff's counsel, amounting to violations of Rule 10b-5.
    Read More ›
  • Meet the Lawyer Working on Inclusion Rider Language
    At the Oscars in March, Best Actress winner Frances McDormand made “inclusion rider” go viral. But Kalpana Kotagal, a partner at Cohen Milstein Sellers &amp; Toll had already worked for months to write the language for such provisions. Kotagal was developing legal language for contract provisions that Hollywood's elite could use to require studios and other partners to employ diverse workers on set.
    Read More ›